BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16645227)

  • 1. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.
    Thomas C; Kirschbaum A; Boehm D; Thomas L
    Med Oncol; 2006; 23(1):23-36. PubMed ID: 16645227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
    Thomas C; Thomas L
    Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron deficiency and erythropoiesis: new diagnostic approaches.
    Brugnara C
    Clin Chem; 2003 Oct; 49(10):1573-8. PubMed ID: 14500582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Significance of Biomarkers of Iron Deficiency for Anemia in Clinical Practice.
    Petkova NY; Raynov JI; Petrova DY; Ramsheva ZN; Petrov BA
    Folia Med (Plovdiv); 2019 Jun; 61(2):223-230. PubMed ID: 31301666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin, iron metabolism, and red blood cell production.
    Adamson J
    Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypochromic red cells and reticulocyte haemglobin content as markers of iron-deficient erythropoiesis in patients undergoing chronic haemodialysis.
    Cullen P; Söffker J; Höpfl M; Bremer C; Schlaghecken R; Mehrens T; Assmann G; Schaefer RM
    Nephrol Dial Transplant; 1999 Mar; 14(3):659-65. PubMed ID: 10193816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticulocyte hemoglobin measurement--comparison of two methods in the diagnosis of iron-restricted erythropoiesis.
    Thomas L; Franck S; Messinger M; Linssen J; Thomé M; Thomas C
    Clin Chem Lab Med; 2005; 43(11):1193-202. PubMed ID: 16232085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
    Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
    Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
    Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
    Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum transferrin receptor in children: usefulness for determinating the nature of anemia in infection.
    Angeles Vázquez López M; Molinos FL; Carmona ML; Morales AC; Muñoz Vico FJ; Muñoz JL; Muñoz Hoyos A
    J Pediatr Hematol Oncol; 2006 Dec; 28(12):809-15. PubMed ID: 17164650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
    Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
    Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of response to optimize outcome of treatment with erythropoietin.
    Beguin Y
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):27-34. PubMed ID: 9671327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of circulating soluble transferrin receptor level in chronic haemodialysis patients.
    Tarng DC; Huang TP
    Nephrol Dial Transplant; 2002 Jun; 17(6):1063-9. PubMed ID: 12032198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
    Ahluwalia N; Skikne BS; Savin V; Chonko A
    Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Reticulocyte Hemoglobin Content for Diagnosis of Iron Deficiency and Iron Deficiency Anemia, and Monitoring of Iron Therapy: a Literature Review.
    Gelaw Y; Woldu B; Melku M
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
    Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
    Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency.
    Thomas C; Thomas L
    Clin Chem; 2002 Jul; 48(7):1066-76. PubMed ID: 12089176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and differentiation of iron status in anemic very low birth weight infants using a diagnostic nomogram.
    Kasper DC; Widness JA; Haiden N; Berger A; Hayde M; Pollak A; Herkner KR
    Neonatology; 2009; 95(2):164-71. PubMed ID: 18776731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double diagnostic meaning of serum transferrin receptor in hemodialysis patients: two case reports.
    Passanante S; Diquattro M; Greco V; Li Cavoli G; Bono L; Palma B; Scola S; Faraci C; Rotolo U; Menozzi I
    Lab Hematol; 2004; 10(2):61-4. PubMed ID: 15224760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.